FDA
-
-
-
-
-
-
-
XORTX Therapeutics Inc (XRTX) Provides Update on FDA Type B Meeting Request
-
-
-
-
-
-
-
XORTX Therapeutics Inc (XRTX) Adds Late Stage Gout Program to Pipeline
-
-
-
-
-
-
-
XORTX Announces Results of Annual and Special Meeting of Shareholders
-
-
-
-
-
-
-
Today's most important initiations
-
-
-
-
-
-
-
XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study
-
-
-
-
-
-
-
XORTX Announces Submission to European Medicines Agency
-
-
-
-
-
-
-
XORTX Receives Small and Medium Enterprise Status for the European Union
-
324,764 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

